CN112641911A - Medicine for quickly treating enuresis and premature ejaculation - Google Patents

Medicine for quickly treating enuresis and premature ejaculation Download PDF

Info

Publication number
CN112641911A
CN112641911A CN201911004429.7A CN201911004429A CN112641911A CN 112641911 A CN112641911 A CN 112641911A CN 201911004429 A CN201911004429 A CN 201911004429A CN 112641911 A CN112641911 A CN 112641911A
Authority
CN
China
Prior art keywords
medicine
premature ejaculation
enuresis
kidney
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911004429.7A
Other languages
Chinese (zh)
Inventor
王忠民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201911004429.7A priority Critical patent/CN112641911A/en
Publication of CN112641911A publication Critical patent/CN112641911A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/57Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/40Cornaceae (Dogwood family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/46Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/62Nymphaeaceae (Water-lily family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/64Orobanchaceae (Broom-rape family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/894Dioscoreaceae (Yam family)
    • A61K36/8945Dioscorea, e.g. yam, Chinese yam or water yam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9062Alpinia, e.g. red ginger or galangal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for quickly treating enuresis and premature ejaculation, which is prepared by taking ginseng, Chinese yam, gorgon fruit, dried ginger, sharpleaf galangal fruit, raspberry, dogwood, folium cortex eucommiae, cistanche, ginkgo and endothelium corneum gigeriae galli as raw materials and decocting and extracting the raw materials according to a certain weight ratio. The medicine can be prepared into any common oral dosage form, has the functions of strengthening spleen and replenishing qi, tonifying kidney and replenishing essence, absorbing saliva and solidifying urine, strengthening physique and the like, has obvious curative effect on eliminating spleen and kidney deficiency, infantile enuresis, nocturia of the old, spermatorrhea and premature ejaculation, limb weakness, low immune function and other symptoms caused by various diseases, and has particularly quick response and no toxic or side effect.

Description

Medicine for quickly treating enuresis and premature ejaculation
Technical Field
The invention relates to a medicament for quickly treating enuresis and premature ejaculation, in particular to a medicament which is prepared from plant traditional Chinese medicines which are both edible and medicinal as raw materials according to a certain weight ratio and is used for treating spleen and kidney deficiency, infantile enuresis, nocturia of the old, spermatorrhea, premature ejaculation, limb weakness, low immune function and a series of uncomfortable symptoms caused by the hypofunction.
Background
In the real life, people are common to people with spleen and kidney deficiency due to lack of consciousness of people on diet, labor and health care in life. The kidney is the innate root and the spleen is the acquired root, both of which play an extremely important role in human health.
It should be particularly emphasized that although the kidney is the innate, genuine and storing essence viscera, the supplement of acquired essence and micro-substance is especially important, the spleen governs transportation and transformation, and the source of qi and blood generation, and the kidney stores essence and is supplied with energy by the spleen and stomach. However, in real life, some people are unable to eat food and lack of regularity of life, and face a lot of risks in the aspect of food safety, the incidence of diseases is continuously rising, and the probability of spleen and kidney deficiency is obviously increased.
Deficiency of the spleen and kidney has important effects on human body. The traditional Chinese medicine considers that a series of diseases caused by infantile enuresis, nocturia of the old, spermatorrhea, premature ejaculation, limb weakness and low immune function are all internally linked with spleen and kidney deficiency. Starting from the spleen and kidney tonifying, the treatment of the diseases is theoretically reliable. However, in the pharmaceutical market, there is a lack of a special Chinese patent medicine for comprehensively treating infantile enuresis, nocturia of the old, spermatorrhea, premature ejaculation, limb weakness and low immune function.
The traditional Chinese medicine has obvious advantages in the aspect of preventing and treating the diseases, has less side effects compared with western medicines, is easy to accept by patients and has reliable overall curative effect. According to the pathogenesis of infantile enuresis, nocturia of the old, spermatorrhea, premature ejaculation, limb weakness and low immune function, starting from the research of medicine and food dual-purpose traditional Chinese medicines, the traditional Chinese medicine with the functions of tonifying spleen and kidney is mainly selected, the medicines for relieving the symptoms are prepared, the spleen and kidney functions of patients are conditioned and enhanced, and the wide and good development prospect is achieved.
The invention relates to a medicament which has reliable curative effect without toxic or side effect and obvious effect of comprehensively treating infantile enuresis, nocturia of the old, spermatorrhea, premature ejaculation, limb weakness and low immune function, in particular to a medicament which is developed by using medical and edible traditional Chinese medicines and has obvious curative effect, has safe and effective characteristics and very important practical significance, and is the starting point and the research purpose of an inventor. The successful development of a medicine for quickly treating enuresis and premature ejaculation fills the blank of the medicine and food dual-purpose Chinese patent medicine for quickly and effectively treating the diseases, and has very important practical significance and popularization value.
Disclosure of Invention
A medicine for quickly treating enuresis and premature ejaculation is a Chinese patent medicine for warming and invigorating spleen and kidney, securing essence and reducing urination, which is developed mainly aiming at the symptoms of enuresis of children patients, nocturia of the old and nocturnal emission and premature ejaculation of adults.
Infantile enuresis, nocturia of the old, spermatorrhea, premature ejaculation, limb weakness, low immune function and other symptoms, which are internally related in the traditional Chinese medicine. The spleen is the acquired origin, the kidney is the innate origin, and the spleen and kidney have decisive influence on the control of urine, the discharge of semen and the like. The theory of the source of diseases, the indications of miscellaneous diseases of children and enuresis (Bing): for enuresis, the kidney qi descends to yin and urinates because the bladder is deficient cold and cannot confine water, and … … kidneys control water, and the bladder is house of body fluids because of the balance of water, so cold is weak and water cannot be confined, so enuresis is also caused. The kidney governs storing essence, governs water, and the spleen is in the middle energizer, governs transporting and resolving water dampness, governs muscles and limbs, and has an intrinsic connection with limb movement and immunity. Thus, the etiology and pathogenesis of the above symptoms are the same.
There is a common practice that one party treats many diseases and one party is used for treating many diseases in the traditional Chinese medicine. The idea of developing the drug of the present invention is derived from the above-mentioned convention. Mainly strengthens the control ability of the body to water liquid and strengthens the astringency of semen by tonifying spleen and kidney, thereby relieving the enuresis symptom of children caused by congenital kidney qi deficiency, relieving the nocturia increase phenomenon of the old caused by kidney qi deficiency and relieving the spermatorrhea and premature ejaculation symptoms of adults caused by kidney qi loss.
According to pulse syndrome analysis of patients, children who suffer from enuresis often have congenital deficiency and acquired deficiency clinical manifestations, patients who suffer from nocturia and increase of old people often have a history of kidney qi damage and spleen and stomach weakness, adult male patients who suffer from nocturnal emission and premature ejaculation have a history of kidney qi deficiency and kidney essence weakness, and treatment is started from spleen and kidney, spleen and kidney functions are directly enhanced, so that symptoms of infantile enuresis, nocturia of old people, nocturnal emission and premature ejaculation, weakness of limbs, low immune function and the like are eliminated.
The traditional Chinese medicine inheritance studio instructor and the chief Chinese medicine teacher in Tianjin city are explored for many years and believe that the diseases such as spermatorrhea, premature ejaculation, infantile enuresis and frequent micturition of the old are related to the weakness of the function of consolidating and controlling kidney essence, and the function of kidney essence needs to be supplemented by the acquired function of spleen, and the functions of the two are perfect at the same time, so that the symptoms can be avoided or relieved. The above symptoms, although presenting in different clinical manifestations, are consistent in their mechanisms, which are intrinsically linked to the innate kidney and the acquired spleen. The treatment should mainly tonify the kidney and replenish essence, invigorate the spleen and replenish qi, and simultaneously give consideration to the symptoms, treat both symptoms and root causes, and hope to quickly relieve various symptoms.
The medicine is realized by the following technical scheme. The medicine for quickly treating enuresis and premature ejaculation is characterized by being prepared from the following raw materials in parts by weight by using a conventional process of Chinese materia medica pharmaceutics: 10-90 parts of ginseng, 10-50 parts of Chinese yam, 10-90 parts of gordon euryale seed, 10-60 parts of dried ginger, 10-60 parts of sharpleaf galangal fruit, 10-90 parts of raspberry, 10-60 parts of dogwood, 10-90 parts of eucommia leaf, 10-50 parts of cistanche, 10-90 parts of ginkgo and 10-60 parts of chicken's gizzard-membrane.
The raw material medicaments and the dosage formula are obtained by the inventor through combined clinical tests of many medical institutions for many years, and have obvious curative effect within the dosage range.
The Chinese medicine composition for quickly curing enuresis and prospermia is made up by using ginseng, Chinese yam, gordon euryale seed, dried ginger, alpinia fruit, raspberry, cornus fruit, eucommia leaf, cistanche stem, ginkgo seed and gizzard lining through a certain preparation process, and can produce mutual synergistic action between the medicinal functions, and possesses the functions of invigorating spleen and supplementing qi, tonifying kidney and replenishing essence, arresting saliva and curing enuresis, and strengthening physique, etc.
The ginseng in the medicine for quickly curing enuresis and premature ejaculation has the functions of greatly invigorating primordial qi, recovering pulse, relieving depletion, nourishing blood, promoting production of body fluid, tranquilizing the mind and promoting intelligence development, has obvious relieving effect on deficiency of qi and blood, limb weakness and the like, and can improve immunity, enhance memory, improve cardiovascular function and delay senility; the Chinese yam has the effects of tonifying spleen and qi, helping digestion and stopping diarrhea, replenishing essence and reinforcing kidney, improving digestive function, improving immunity, relieving frequent micturition and enuresis, relieving spermatorrhea and premature ejaculation, promoting kidney regeneration and repair, resisting oxidation and aging, and has obvious effect on strengthening physique; the gorgon fruit has the effects of tonifying spleen, checking diarrhea, tonifying kidney, controlling nocturnal emission, clearing damp, reducing urination, relieving frequent urination, resisting oxidation, aging, tumors and kidney, and the like; the dried ginger has the effects of warming the middle-jiao to dispel cold, restoring yang and dredging collaterals, is good for treating spleen-kidney yang deficiency, has the effects of resisting inflammation, sterilizing, resisting oxidation, resisting tumors and resisting platelet aggregation, and has a certain effect on nocturia and enuresis caused by spleen-kidney yang deficiency through clinical verification; fructus Alpinae Oxyphyllae has effects of warming spleen, relieving diarrhea, invigorating kidney, reducing urination, tonifying heart, resisting aging, resisting allergy, resisting tumor, improving intelligence, tranquilizing mind, and relieving pain; the raspberry has the effects of nourishing liver and kidney, securing essence and reducing urination, warming kidney and tonifying yang, has the effects of resisting aging, resisting oxidation, resisting inflammation, promoting intelligence and the like, and has certain curative effect on senile nocturia and frequent micturition and children enuresis; corni fructus has effects of invigorating liver and kidney, astringing essence, reducing urination, arresting sweating, relieving depletion, enhancing immunity, resisting oxidation, resisting tumor, lowering blood sugar, improving cognitive ability, and protecting nervous system; folium Eucommiae has effects in nourishing liver and kidney, invigorating spleen, invigorating qi, strengthening tendons, consolidating constitution, tranquilizing mind, relieving pain, enhancing immunity, delaying aging, improving glycometabolism, resisting bacteria, virus and oxidation, lowering blood pressure, reducing blood lipid, and protecting central nervous system; cistanchis herba has effects of invigorating kidney yang, replenishing essence, replenishing marrow, loosening bowel to relieve constipation, enhancing immunity, resisting oxidation, resisting aging, protecting liver, relieving fatigue, promoting libido, protecting nerve, and enhancing memory; the roasted ginkgo has the function of contracting the sphincter of the bladder, has good auxiliary treatment efficacy on diseases such as infantile enuresis, frequent urination due to qi deficiency, leukorrhagia with whitish and turbid urine, unconsolidation of spermatorrhea and the like, and has the functions of resisting inflammation, resisting bacteria, toxicity, resisting oxidation, removing free radicals, regulating blood sugar and blood fat, improving liver function, resisting aging, regulating immunity, resisting tumors, improving nervous system and the like; the endothelium corneum gigeriae galli has the effects of invigorating stomach and helping digestion, and can be used for controlling nocturnal emission, reducing urination, stopping enuresis and treating stranguria, and clinical researches prove that the traditional Chinese medicine composition can be used for treating symptoms such as spermatorrhea, enuresis and the like caused by various reasons.
A Chinese medicine for quickly treating enuresis and premature ejaculation has the functions of invigorating spleen, benefiting vital energy, invigorating kidney, replenishing essence, controlling saliva, consolidating urine, and improving physique. Moreover, the medicines are not the superposition of the effects of single traditional Chinese medicines, but are scientifically prepared on the basis of the treatment based on syndrome differentiation of the traditional Chinese medicine, and the formula effect of 1+1 to more than 2 is realized. The traditional Chinese medicine is mainly embodied in regulating spleen and kidney, securing essence and reducing urination, and has obvious effects of treating infantile enuresis, nocturia of the old, spermatorrhea, premature ejaculation, limb weakness, low immune function and other symptoms.
Moreover, the pharmacological actions of the medicines have related pharmacological research or animal test conclusions.
The medicine can be prepared into oral administration dosage forms by adopting a conventional method of Chinese medicine preparations. The medicine of the invention can be prepared by grinding the raw materials into powder and uniformly mixing the powder into powder, granules, oral liquid and beverage. The raw materials can be decocted in water and then concentrated into decoction to obtain effective components, and then the effective components are prepared into various oral preparations, but the invention is not limited by the protection scope of the invention.
The medicine can also be used for extracting effective components by adopting methods such as semi-bionic extraction (SBE), Supercritical Fluid Extraction (SFE), microwave extraction (MAE), enzyme extraction (ETE), ultrasonic extraction (UAE), semi-bionic extraction (SEB), squeezing extraction (PE), Continuous Countercurrent Extraction (CCE), tissue disruption extraction (STE), heating-free extraction (HFE), normal-temperature ultrahigh-pressure extraction (U HPE), Air Explosion Extraction (AEE) and the like, and the extraction methods are all in the protection range of the medicine.
The following capsule formulations are preferred for use in the present invention.
The preparation method of the medicine comprises the following steps:
(1) weighing the raw materials in proportion for later use;
(2) 11 traditional Chinese medicines of ginseng, Chinese yam, gordon euryale seed, dried ginger, sharpleaf galangal fruit, raspberry, dogwood, eucommia ulmoides leaf, desertliving cistanche, ginkgo and chicken's gizzard-membrane in the weight ratio are delivered to a professional traditional Chinese medicine pharmaceutical factory for extraction after being checked and accepted;
(3) extracting by a pharmaceutical factory according to a conventional method and a conventional program for extracting traditional Chinese medicines;
(4) packaging the extracted medicinal powder into bottled capsules, wherein each bottle contains 60 capsules, and each capsule contains 0.45g of the Chinese medicinal extract powder;
(5) or making the extracted medicine into granules, wherein each bag contains 6g of traditional Chinese medicine extraction powder;
(6) the finished product is delivered to clinical trials by the pharmaceutical factory.
The clinical use results show that the medicine of the invention has the following advantages:
1. the invention selects natural edible plant medicines as raw materials, and each component accords with the regulation of a pharmaceutical law and the principle of a traditional Chinese medicine prescription, and highlights the basic characteristics of the combination of traditional Chinese medicine syndrome differentiation and western medicine disease differentiation and the combination of etiology treatment and symptomatic treatment;
2. the medicine of the invention does not need to be decocted after being extracted, has good taste and convenient taking, is nontoxic and harmless before and after the prescription of each medicine, and has no side effect after being taken with normal dosage;
3. the medicine has good treatment effect on diseases such as spermatorrhea, premature ejaculation, infantile enuresis and frequent micturition of old people, has good effects of prevention, health care and the like, and has wide application range;
4. the medicine is selected from the varieties which can be used as both medicine and food and specified in Wei Jian Wei, has higher safety, and can be taken by patients with deficiency of middle-jiao and kidney essence for a long time;
5. the medicine has good compatibility, and has certain compatibility treatment effect on sub-health symptoms such as complications, low immunity, limb weakness and the like which are easy to appear in patients;
6. the medicine of the invention treats both principal and secondary aspect of disease, and has quick effect.
Detailed Description
The effect of the present invention will be further illustrated by the following examples and clinical application statistics.
Example 1: capsule preparation
6kg of ginseng, 15kg of Chinese yam, 18kg of gordon euryale seed, 12kg of dried ginger, 15kg of sharpleaf galangal fruit, 15kg of raspberry, 15kg of dogwood, 15kg of eucommia leaf, 12kg of cistanche, 10kg of ginkgo and 10kg of chicken's gizzard-membrane are extracted and processed by a professional Chinese medicine pharmacy factory to prepare capsules, wherein each capsule is 0.45g, 2-4 capsules each time, and 3 times a day.
Example 2: beverage preparation
6kg of ginseng, 15kg of Chinese yam, 18kg of gordon euryale seed, 12kg of dried ginger, 15kg of sharpleaf galangal fruit, 15kg of raspberry, 15kg of dogwood, 15kg of eucommia leaf, 12kg of cistanche, 10kg of ginkgo and 10kg of chicken's gizzard-membrane are extracted and processed by a professional Chinese medicine pharmacy and are prepared into granules, 6g of the granules are taken with water in 1-2 bags each time for 3 times a day.
Clinical observation of the medicine for treating infantile enuresis
1. General data
In order to prove the clinical curative effect of the medicine for treating infantile enuresis, in 7-2019 and 5-2018 months in the outpatient clinic of traditional Chinese medicine gynecology, 112 cases of enuresis patients are treated, wherein the patients are 5-13 years old and average (7.1 +/-2.79) years old; 85 men and 27 women; the shortest disease course is 3 months, the longest course is 7 years and 2 months, and the average (3.1 +/-2.75) years; the test pieces were divided into an observation group and a control group according to a digital random table method, and 56 cases were used in each of the 2 groups. The general clinical data of age, sex, course, etc. of two groups have no significant difference after statistical treatment and are comparable (P > 0.05).
Diagnostic criteria: the method is determined according to the diagnosis standard of infantile enuresis in the infant science of traditional Chinese medicine: the onset age is over 3 years old, the urine comes out when people sleep, and enuresis can be felt after waking; the sleep is deep and not easy to wake up, and enuresis occurs at night or every few days, even occurs for many times at night; the urinary routine and the urinary culture are both found to be abnormal, and organic lesions are eliminated through related examination.
Inclusion criteria were: meets the Chinese and western medicine clinical diagnosis standard of infantile enuresis, and can be used for complete medicine application by giving consent to parents or guardians of infants.
Exclusion criteria: patients with congenital urinary malformation, nervous system diseases, metabolic diseases such as enuresis caused by diabetes and diabetes insipidus, etc., patients allergic to known traditional Chinese medicine components, and patients with poor compliance and influence on curative effect judgment.
2. Test method
Comparison medication: the observation group uses the medicine granule of the invention, and the children patients of 5-10 years old have 6g of the medicine granule each time and 3 times/d; the dose is 9g for children older than 10 years, 3 times per day. The control group takes concentrated shrinkage spring pills produced by Shanghai Leying Shang pharmaceutical Co Ltd, and the children patients of 5-10 years old take 6g for 3 times/d each time; the dose is 8g for children older than 10 years, 3 times per day. Both groups were discontinued during treatment with all relevant drugs for this disease. Encourages the sick children to drink more water or fluid in the daytime, pay attention to exercise for holding urine, prolong urination time, fully fill the bladder, exercise the function of the bladder and expand the volume of the bladder; order the infant patient not to drink water and fluid within 2 hours before sleeping, and empty urine before falling asleep. The two groups of continuous treatment time was 12 weeks.
Observation indexes are as follows: recording the number of urination per week on the treatment days 1 and 21 respectively; according to the 'traditional Chinese medicine disease diagnosis curative effect standard' issued by the State administration of traditional Chinese medicine, the reduction of nocturnal enuresis times per week before and after treatment of two groups of children patients is counted, and comparative analysis of curative effect is carried out. The method for calculating the percentage reduction of enuresis, namely the curative effect index, comprises the following steps: the curative effect index is (number of enuresis before treatment-number of enuresis after treatment)/number of enuresis before treatment x 100%.
And (3) evaluating the curative effect: the clinical control is that the curative effect index is more than or equal to 90 percent; the curative effect index is more than or equal to 60 percent and less than 90 percent; the curative effect index is improved when the curative effect index is more than or equal to 30 percent and less than 60 percent; the symptoms are not improved basically within 20 days after the medicine is taken, and the curative effect index is less than 30 percent, which is invalid.
Statistical analysis: statistical analysis is carried out by adopting SPSS10.0 for windows statistical software, and Chi is adopted for comparing the curative effects of the two groups2The test shows that P is less than 0.05, which shows that the difference is statistical.
The treatment results are as follows: in 56 observation groups, 37 clinical control cases (66.1%), 11 significant effects (19.6%), 6 improvement cases (10.7%), 2 ineffective cases (3.6%) and 96.4% of total effective rate are achieved; 56 cases in the control group achieve 9 cases (16.1%) of clinical control, 13 cases (23.2%) of significant effect, 15 cases (26.8%) of improvement, 19 cases (33.9%) of ineffective effect and 66.1% of total effective rate. The clinical control rate and the total effective rate of an observation group are higher than those of a control group, and P is less than 0.05.
Second, the clinical observation of the medicine of the invention for treating premature ejaculation
1. General data
In order to prove the clinical curative effect of the medicine for treating premature ejaculation, 92 cases of premature ejaculation patients are treated by outpatient service of traditional Chinese medicine department in 5-2019 and 3-2018, the patients are 27-55 years old and the average (35.9 +/-12.91) years old; the shortest disease course is 6 months, the longest course is 3 years and 6 months, and the average (1.7 +/-1.12) years; dividing into an observation group and a control group according to a digital random table method, wherein the observation group and the control group are 46 cases. The general clinical data of age, disease course, etc. of two groups have no significant difference after statistical treatment and are comparable (P is more than 0.05).
Diagnostic criteria: for the currently accepted standard of premature ejaculation, refer to "diagnostic and statistics manual for psychosis" (D sMW), issued by the American society for psychosis. Mainly embodied in the following 3 aspects: continuously or repeatedly with little sexual stimulation, ejaculation is carried out before, during or shortly after the insertion of the vagina, which is obviously ahead of the personal wish; premature ejaculation obviously causes pain of the person and tension of the relationship between sexual partners; premature ejaculation is not caused by the withdrawal of certain psychoactive substances (e.g. opiate withdrawal, etc.). In general, the ejaculation latency is less than 1min, and the onset time is more than 1 month.
Grading the weight: the penis is inserted into the vagina and can be drawn, but the ejaculation is mild within 1 min; when the penis is inserted into the vagina, the ejaculation is moderate; the penis is not inserted into the vagina yet, the two parts are not contacted or just contacted, and the spontaneous abortion, namely the ejaculation is severe.
Inclusion criteria were: meets the above premature ejaculation diagnosis standard; are not exclusive of the standard; the patient can voluntarily participate in clinical observation and can actively finish the treatment.
Exclusion criteria: ejaculation latency period > 1 min; those < 20 years of age or > 65 years of age; inflammation of genitourinary system, such as prostatitis, urethritis, epididymitis, and seminal vesiculitis; organic diseases of penis, such as phimosis and redundant prepuce; other premature ejaculation treating medicines are taken during the treatment period; patients with primary diseases of heart, liver, kidney and nervous system; patients who do not take the medicine on time, quit midway, have irregular sexual life, lose contact and lose visits.
Traditional Chinese medicine syndrome differentiation: premature ejaculation and nocturnal emission, sexual desire but forceful feeling, weakness of waist and knees, cold and cold body, dizziness and tinnitus, limb weakness, lassitude, memory decline, nocturia, inappetence, constipation, clear and long urine, pale tongue, thin and white fur and thready and weak pulse, and accords with the spleen-kidney yang deficiency syndrome in the traditional Chinese medicine.
2. Test method
Comparison medication: the observation group uses the medicine capsules of the invention, each capsule is 0.45g, 4 capsules 1 time and 3 times per day; the control group is orally administered with GUIFUDIHUANG pill concentrated pill (Henan Zhongjing pharmaceutical industry GmbH, Chinese medicine QUI-type Z20055108) 1 time 8 pills and 3 times/d. Both groups were discontinued during treatment with all relevant drugs for this disease. The two groups had 3 months of continuous treatment.
Observation indexes are as follows: after medication, the ejaculation time is observed to determine the treatment effect.
And (3) evaluating the curative effect: the patients who can have normal sexual intercourse after the treatment by the method are cured clinically; the improvement from severe premature ejaculation to moderate or mild premature ejaculation or from moderate premature ejaculation to mild premature ejaculation is improved after the treatment by the method; the treatment method is not effective when the premature ejaculation degree is not improved or aggravated.
Statistical analysis: statistical analysis is carried out by adopting SPSS10.0 for windows statistical software, and Chi is adopted for comparing the curative effects of the two groups2The test shows that P is less than 0.05, which shows that the difference is statistical.
The treatment results are as follows: in 46 observation groups, 38 clinical cases (82.6%) are cured, 6 clinical cases (13.0%) are improved, 2 clinical cases (4.4%) are invalid, and the total effective rate is 95.6%; in 46 cases of the control group, 12 cases (26.1%) are clinically cured, 19 cases (41.3%) are improved, 15 cases (32.6%) are ineffective, and the total effective rate is 67.4%. The clinical cure rate and the total effective rate of an observation group are higher than those of a control group, P is less than 0.05, and the medicine has certain popularization value in treating premature ejaculation caused by spleen-kidney yang deficiency.

Claims (7)

1. The formula of the medicine for quickly treating enuresis and premature ejaculation is characterized in that the medicine is prepared from the following medicinal and edible traditional Chinese medicines in parts by weight:
Figure FSA0000192853490000011
2. the medicament for rapidly treating enuresis and premature ejaculation as claimed in claim 1, wherein the formulation is prepared into capsules by a conventional process of Chinese materia medica pharmaceutics.
3. The medicament for rapidly treating enuresis and premature ejaculation as claimed in claim 1, wherein the formulation is prepared into tablets by adopting the conventional process of Chinese materia medica preparation.
4. The medicine for rapidly treating enuresis and premature ejaculation as claimed in claim 1, wherein the formula is prepared into powder or granules by adopting the conventional process of Chinese materia medica pharmaceutics.
5. The medicament for rapidly treating enuresis and premature ejaculation as claimed in claim 1, wherein the formulation is prepared into water pills, honey pills, water-honey pills, concentrated pills or dripping pills by using the conventional process of Chinese materia medica pharmaceutics.
6. The medicine for rapidly treating enuresis and premature ejaculation as claimed in claim 1, wherein the formula is characterized in that the oral liquid is prepared by adopting the conventional process of Chinese materia medica pharmaceutics.
7. The medicine for rapidly treating enuresis and premature ejaculation as claimed in claim 1, wherein the formula is characterized in that the medicine is prepared into tea by adopting the conventional process of Chinese materia medica pharmaceutics.
CN201911004429.7A 2019-10-10 2019-10-10 Medicine for quickly treating enuresis and premature ejaculation Pending CN112641911A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911004429.7A CN112641911A (en) 2019-10-10 2019-10-10 Medicine for quickly treating enuresis and premature ejaculation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911004429.7A CN112641911A (en) 2019-10-10 2019-10-10 Medicine for quickly treating enuresis and premature ejaculation

Publications (1)

Publication Number Publication Date
CN112641911A true CN112641911A (en) 2021-04-13

Family

ID=75343211

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911004429.7A Pending CN112641911A (en) 2019-10-10 2019-10-10 Medicine for quickly treating enuresis and premature ejaculation

Country Status (1)

Country Link
CN (1) CN112641911A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115252735A (en) * 2022-09-15 2022-11-01 湖南德泽园医药科技有限公司 Traditional Chinese medicine composition and application thereof, and preparation method of traditional Chinese medicine medicament

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1256132A (en) * 1998-12-08 2000-06-14 苗海旺 Medicine for enuresis and its preparation
CN1615974A (en) * 2004-10-14 2005-05-18 姜丽霞 Medicine for treating bed-wetting
CN1824124A (en) * 2005-12-29 2006-08-30 颜怀伟 Medicine and food dual purpose Chinese medicinal health care product for preventing and treating impotence premature ejacuation emission and its manufacturing method
CN109939195A (en) * 2017-12-20 2019-06-28 袁龙 A kind of herbal paste and preparation method for treating the enuresis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1256132A (en) * 1998-12-08 2000-06-14 苗海旺 Medicine for enuresis and its preparation
CN1615974A (en) * 2004-10-14 2005-05-18 姜丽霞 Medicine for treating bed-wetting
CN1824124A (en) * 2005-12-29 2006-08-30 颜怀伟 Medicine and food dual purpose Chinese medicinal health care product for preventing and treating impotence premature ejacuation emission and its manufacturing method
CN109939195A (en) * 2017-12-20 2019-06-28 袁龙 A kind of herbal paste and preparation method for treating the enuresis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115252735A (en) * 2022-09-15 2022-11-01 湖南德泽园医药科技有限公司 Traditional Chinese medicine composition and application thereof, and preparation method of traditional Chinese medicine medicament
CN115252735B (en) * 2022-09-15 2024-04-19 湖南德泽园医药科技有限公司 Traditional Chinese medicine composition and application thereof and preparation method of traditional Chinese medicine medicament

Similar Documents

Publication Publication Date Title
CN101327297B (en) Chinese medicine composition for treating insomnia
CN101693102A (en) Traditional Chinese medicine compound for treating diseases of incoordination between the spleen and the stomach and abdominal fullness and distention and preparation method thereof
CN104606612A (en) Alcohol-expelling kidney-tonifying tablet candy and preparation method thereof
CN100411676C (en) Traditional Chinese medicine prepn. for preventing infantile respiratory tract infection repeatedly and treating hypopepsia
CN104474341B (en) A kind of pharmaceutical composition for the treatment of hyperkinetic syndrome
CN103565969B (en) Traditional Chinese medicine composition for treating soft tissue injury and fracture
CN105213738A (en) A kind of Chinese medicine being used for the treatment of infantile constipation and preparation method thereof
CN112641911A (en) Medicine for quickly treating enuresis and premature ejaculation
CN103495042A (en) Traditional Chinese medicine composition for treating migraine
CN103100072B (en) Traditional Chinese medicine composition for treating proctitis and appendicitis, and restraining rectum cancer
CN102028865A (en) Medicinal composition for relieving cough and reducing sputum and method for preparing same
CN106039225A (en) Traditional Chinese medicine preparation for treating acute lumbar muscle sprain
CN103417896A (en) Drug-addiction-stopping tea and preparation method thereof
CN107184701B (en) Traditional Chinese medicine composition for treating schizophrenia, preparation method and application thereof
CN111419933A (en) Traditional Chinese medicine composition for tonifying spleen and promoting appetite and external preparation and application thereof
CN102626506B (en) Traditional Chinese medicine for curing seroperitoneum
CN104042739A (en) Traditional Chinese medicine for treating prospermia
CN103961578A (en) Traditional Chinese medicine medicinal liquor for treating neurasthenia
CN116688058B (en) Li medicine for impotence, preparation method and application thereof
CN103157011B (en) Traditional Chinese medicine composite for promoting fracture healing
CN112439037B (en) Medicine for relieving fatigue syndrome
CN107837331A (en) A kind of Chinese medicine composition for treating insomnia and preparation method thereof
CN101732648B (en) Medicament for treating nonunion
CN106692707A (en) Xuanyun Ning
CN106389738A (en) Traditional Chinese medicine granules for treating constipation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination